Testing effectiveness (Phase 2)Study completedNCT00916097
What this trial is testing
NPC Study : TAX + CIS Neoadjuvant in Patients With Loco Regionally Advanced Undifferentiated Carcinoma of Nasopharyngeal Type (UCNT)
Who this might be right for
Head and Neck Neoplasms
Sanofi 66